The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives

Taixiong Chen,Li Zhou,Ke Wang,Xiao Ma,Haiya Wu,Xin Liu, Jingyu Tong, Bojing Cai,Qiuhe Ji

Clinical Therapeutics(2020)

引用 4|浏览9
暂无评分
摘要
•Chinese endocrinologists have good understanding of patient concerns on initiating IAT.•Improvement on drug portability/storage, injection site reactions, operation of device, and needle design could increase Chinese diabetic patients' satisfaction.•IAT with less steps for injection, less side effects, more convenient drug portability/storage could reduce training duration for HCPs.
更多
查看译文
关键词
glucagon-like peptide 1 receptor agonist,insulin,perception,satisfaction,training burden,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要